Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Surya Pharma Initiates Commercial Manufacturing At Jammu Plant
Surya Pharma said that its Jammu plant has the capability to manufacture APIs and sterile products as per the norms of the FDA. Surya Pharma, a Chandigarh-based pharmaceutical
Surya Pharma said that its Jammu plant has the capability to manufacture APIs and sterile products as per the norms of the FDA. Surya Pharma, a Chandigarh-based pharmaceutical
As per the terms of the expanded agreement, Keith Kendall, executive vice president and chief financial officer of MonoSol Rx, is expected to join Midatech board of directors.
SOCMA’s new members include: Arichem, Huffmaster, Marsh USA, NCM Hersbit Chemical and NCM Hersbit Chemical. The companies, who range from specialty chemical manufacturers to security providers to insurance
The patent, when issued, will provide Japanese patent protection to September 2021 and is one in a series of patents and pending applications that NexMed owns on Vitaros
As per the agreement, QED is expected to generate monoclonal antibodies against several disease specific epitopes (DSE’s) on misfolded CD38 protein. The DSE’s were identified by Amorfix using
Nektar said that the study is being conducted at University Hospitals Case Medical Center of the Case Comprehensive Cancer Center in Cleveland, Ohio. NKTR-102 is a novel topoisomerase
The approval of Dulera is based, in part, on Phase III studies that evaluated the safety and efficacy in patients 12 years of age and older with persistent
Neogenix said that the USPT0 has issued a patent for the NPC-1C monoclonal antibody and a related divisional patent was granted with respect to the genes encoding the
Procardia XL extended release tablet is designed to provide nifedipine at an approximately constant rate over 24 hours. The controlled rate of drug delivery into the gastrointestinal lumen
With this positive opinion, CHMP has recommended the European Commission to grant the European Marketing Authorisation (MA). The product will be marketed in the EU under the name